This was true for both PyMT Timp3+/+ (p = 0.0114) and PyMT Timp3−⁄− donor cells (p = 0.0717), and importantly, 50–60% of these Timp3−⁄− experimental recipients remained tumor free at 120 days. This evidence concerns the gene TIMP3 and neoplasm.